Switzerland
2

Healthcare and life sciences

logo

Pestalozzi

Plus d’information
Franz Schubiger, Lara Dorigo, and Christian Roos jointly lead the Zurich-based team at Pestalozzi, which is well-placed to assist with collaboration agreements, the financing of research projects, and the full range of issues relating to distribution and licensing. Schubiger is a key contact for financial investors, SMEs, and major corporations across the biotech and pharma spaces. Dorigo routinely acts in patent litigation involving biologics and medtech products, while Roos handles the employment aspects of M&A and corporate restructurings. Sarah Drukarch regularly advises on major R&D projects and marketing authorisations, and Alexandra Bühlmann is particularly adept at handling unfair competition mandates.
L’éditorial du Legal 500
Profil
pestalozzilaw.com

Témoignages

Collectés indépendamment par l'équipe de recherche du Legal 500.

  • ‘Expertise in all areas of business law (one stop shop); capability to advise on international, cross-border and very complex matters with a responsive and customised team. Really works together as a team and as a business partner with the client to take into consideration all aspects of the transaction.’

  • ‘We work in particular with Franz Schubiger, who has an outstanding capacity for truly listening to and understanding the business and the interests of the company, but also the concerns and perspectives of the different stakeholders of the family enterprise. He gives strategic, actionable and pragmatic advice and is able to think 2 or 3 steps ahead. Flexible, responsive and very reliable.’

  • ‘Excellent knowledge of local law and practice, availability, counsel on litigation, patent invalidation and on practical and strategic aspects linked to the Swiss law in the pharma sector.’

  • ‘Lara Dorigo and Alexandra Bühlmann: in addition to their outstanding knowledge of the technical area and of local law, they have provided advice in a timely and clear manner, with a strategic outlook and full discussion of the possible scenarios.’

Clients clés

  • Astellas Pharma Europe, belonging to Astellas Pharma, Inc.
  • European Investment Bank
  • Flavorchem & Orchidia Fragrances
  • GE Healthcare
  • GE Medical Systems (Switzerland)
  • Gilead Sciences
  • Kite Pharma
  • Johnson & Johnson
  • DePuy Synthes
  • Janssen Pharmaceutica NV

Points forts

  • Advised Flavorchem on its acquisition of all shares in Dr. W. Huber AG.
  • Represented Zentiva Group / Helvepharm in patent litigation proceedings regarding the launch of a rivaroxaban generic in Switzerland.
  • Advising Johnson & Johnson on a broad range of Swiss legal and tax matters relating to its subsidiaries operating in and from Switzerland.

Avocats

Responsable de la pratique

Franz Schubiger; Lara Dorigo; Christian Roos

Autres avocats clés

Sarah Drukarch; Alexandra Bühlmann